Regarding PRSS1, its serum levels were found to be significantly lower in human leucocyte antigen death receptor (HLA-DR)+ compared to HLA-DR− ALL patients (p = 0.0239, Fig. 4C). This evidence concerns the gene PRSS1 and acute lymphoblastic leukemia.